Quick Answer
Universe Pharmaceuticals INC reported Diluted EPS of $8.06 per share (loss) for fiscal year 2025.
Universe Pharmaceuticals INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$8.06 | +98.7% |
| 2024 | -$626.96 | +42.4% |
| 2023 | -$1089.21 | +16.8% |
| 2022 | -$1309.11 | -36667.3% |
| 2021 | $3.58 | +661.7% |
| 2020 | $0.47 | — |
- Universe Pharmaceuticals INC showed an increase of +98.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Universe Pharmaceuticals INC’s diluted eps has declined by 1814.9% (from $0.47 per share to $8.06 per share (loss)).
- The most recent figure is from Universe Pharmaceuticals INC’s fiscal year 2025 report (Form 20-F), filed with the SEC on January 29, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: